Patents Assigned to University of Massachuetts
  • Publication number: 20130072650
    Abstract: The invention provides certain novel water-soluble and water-insoluble monomers for ring opening metathesis polymerization and novel polymers, compositions and products, and related methods thereof.
    Type: Application
    Filed: November 11, 2012
    Publication date: March 21, 2013
    Applicant: University of Massachuetts
    Inventor: University of Massachusetts
  • Publication number: 20020183594
    Abstract: A device for retracting edges of an incision in a surface to form an opening including: a flexible, tubular skirt having an upper end, a lower end, and a channel therebetween; a ring connected to the lower end of the skirt for maintaining the lower end in an open configuration and defining an exit opening to the channel; and an inflatable collar connected to the skirt and surrounding the upper end. The ring is designed to fit through the incision and remain under the surface when it is oriented parallel to surface. The collar, when inflated, maintains the upper end in an open configuration and defines an entry opening to the channel. During use, the ring is inserted through the incision and the collar is inflated while remaining outside of the incision, thereby drawing the skirt against he edges of the incision and retracting the edges of the incision to form the opening.
    Type: Application
    Filed: July 1, 2002
    Publication date: December 5, 2002
    Applicant: University of Massachuetts, a Massachusetts corporation
    Inventors: Richard Beane, Steve Ek, Allison C. Niemann, Maureen E. Carroll, Randall J. Hasslinger, Edward I. Stamm, Javier Verdura
  • Patent number: 6365352
    Abstract: The present invention comprises a method to identify granulocytic cell genes that are differentially expressed upon exposure to a pathogen or in a sterile inflammatory disease by preparing a gene expression profile of a granulocytic cell population exposed to a pathogen or isolated from a subject having a sterile inflammatory disease and comparing that profile to a profile prepared from quiescent granulocytic cells. The present invention is particularly useful for identifying cytokine genes, genes encoding cell surface receptors and genes encoding intermediary signaling molecules. The invention also includes methods to identify a therapeutic agent that modulates the expression of at least one gene in a granulocytic population. Genes which are differentially expressed during neutrophil contact with a pathogen, such as a virulent bacteria, or that are differentially expressed in a subject having a sterile inflammatory disease are of particular importance.
    Type: Grant
    Filed: February 18, 2000
    Date of Patent: April 2, 2002
    Assignees: Yale University, Gene Logic, INC, University of Massachuetts
    Inventors: Subrahmanyam V. Yerramilli, Yatindra Prashar, Peter Newburger, Jon Goguen, Sherman M. Weissman